Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease ; volume:11 ; number:1 ; day:4 ; month:2 ; year:2019 ; pages:1-6 ; date:12.2019
Alzheimer's research & therapy ; 11, Heft 1 (4.2.2019), 1-6, 12.2019

Creator: Hanseeuw, Bernard J.
Lopera, Francisco
Sperling, Reisa A.
Norton, Daniel J.
Guzman-Velez, Edmarie
Baena, Ana
Pardilla-Delgado, Enmanuelle
Schultz, Aaron P.
Gatchel, Jennifer
Jin, David
Chen, Kewei
Reiman, Eric M.
Johnson, Keith A.
Quiroz, Yakeel T.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-019-0468-1

URN: urn:nbn:de:101:1-2019031000152593941279

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hanseeuw, Bernard J.
Lopera, Francisco
Sperling, Reisa A.
Norton, Daniel J.
Guzman-Velez, Edmarie
Baena, Ana
Pardilla-Delgado, Enmanuelle
Schultz, Aaron P.
Gatchel, Jennifer
Jin, David
Chen, Kewei
Reiman, Eric M.
Johnson, Keith A.
Quiroz, Yakeel T.
SpringerLink (Online service)

Other Objects (12)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

Familial Alzheimer’s Disease and Recessive Modifiers

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Fazekas scale magnetic resonance imaging assessment in Alzheimer’s disease and primary age-related tauopathy

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease

Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

Familial Alzheimer’s Disease and Recessive Modifiers

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Fazekas scale magnetic resonance imaging assessment in Alzheimer’s disease and primary age-related tauopathy

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease

Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

Familial Alzheimer’s Disease and Recessive Modifiers

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Fazekas scale magnetic resonance imaging assessment in Alzheimer’s disease and primary age-related tauopathy

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease

Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

Familial Alzheimer’s Disease and Recessive Modifiers

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Fazekas scale magnetic resonance imaging assessment in Alzheimer’s disease and primary age-related tauopathy

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease

Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

Familial Alzheimer’s Disease and Recessive Modifiers

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Fazekas scale magnetic resonance imaging assessment in Alzheimer’s disease and primary age-related tauopathy

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease

Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

Familial Alzheimer’s Disease and Recessive Modifiers

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Fazekas scale magnetic resonance imaging assessment in Alzheimer’s disease and primary age-related tauopathy

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease

Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Related objects

Reset password